Spots Global Cancer Trial Database for zoledronate
Every month we try and update this database with for zoledronate cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone | NCT00301886 | Breast Cancer Hypercalcemia o... Metastatic Canc... Pain | ibandronate zoledronate quality-of-life... | 18 Years - | SWOG Cancer Research Network | |
PET Scanning to Evaluate Zoledronate Efficacy in Metastatic Prostate Cancer | NCT01205646 | Prostate Cancer | zoledronate the... PET Scan | - | Barbara Ann Karmanos Cancer Institute | |
Zoledronate in Treating Patients With Cervical Intraepithelial Neoplasia 2/3 or 3 | NCT00278434 | Cervical Cancer Precancerous Co... | Zoledronate Placebo (Saline... | 18 Years - 120 Years | University of California, San Francisco | |
Neoadjuvant Zoledronate and Atorvastatin in Triple Negative Breast Cancer | NCT03358017 | Triple Negative... | Zoledronate Atorvastatin 80... Standard neoadj... | 18 Years - | Mario Negri Institute for Pharmacological Research | |
Bone Loss Treatment From Adjuvant Zoledronate Efficacy | NCT01623908 | Breast Neoplasm... Bone Loss | Zoledronate | 18 Years - | First Affiliated Hospital, Sun Yat-Sen University | |
Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid | NCT00295646 | Breast Cancer | tamoxifen anastrozole zoledronic acid goserelin | 19 Years - 59 Years | Austrian Breast & Colorectal Cancer Study Group | |
Comparison of Ibandronate - Zoledronate Regarding Nephrotoxicity in Multiple Myeloma | NCT02739594 | Multiple Myelom... | Ibandronate Zoledronate | 18 Years - | Hoffmann-La Roche | |
Bone Mineral Density Effects of Zoledronate in Postmenopausal Women With Breast Cancer | NCT00213980 | Breast Cancer | Zoledronate | 18 Years - | University of Wisconsin, Madison | |
S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone | NCT00301886 | Breast Cancer Hypercalcemia o... Metastatic Canc... Pain | ibandronate zoledronate quality-of-life... | 18 Years - | SWOG Cancer Research Network | |
Zoledronate in Treating Patients With Cervical Intraepithelial Neoplasia 2/3 or 3 | NCT00278434 | Cervical Cancer Precancerous Co... | Zoledronate Placebo (Saline... | 18 Years - 120 Years | University of California, San Francisco | |
Zoledronate With Atorvastatin in Renal Cell Carcinoma | NCT00490698 | Kidney Cancer Renal Cell Carc... | Zoledronate Atorvastatin | - | M.D. Anderson Cancer Center | |
Bone Loss Treatment From Adjuvant Zoledronate Efficacy | NCT01623908 | Breast Neoplasm... Bone Loss | Zoledronate | 18 Years - | First Affiliated Hospital, Sun Yat-Sen University | |
Bone Mineral Density Effects of Zoledronate in Postmenopausal Women With Breast Cancer | NCT00213980 | Breast Cancer | Zoledronate | 18 Years - | University of Wisconsin, Madison | |
PET Scanning to Evaluate Zoledronate Efficacy in Metastatic Prostate Cancer | NCT01205646 | Prostate Cancer | zoledronate the... PET Scan | - | Barbara Ann Karmanos Cancer Institute | |
Zoledronate With Atorvastatin in Renal Cell Carcinoma | NCT00490698 | Kidney Cancer Renal Cell Carc... | Zoledronate Atorvastatin | - | M.D. Anderson Cancer Center |